# AcoArt Ⅰ / SFA China

Study · id `cardio:ct-nct01850056` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01850056](<https://clinicaltrials.gov/study/NCT01850056>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01850056

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT01850056. Randomized; single masking; primary purpose treatment. Start 2013-04 (actual); primary completion 2016-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT01850056, source copy `cardio:ctgov-nct01850056-2018-07-12`, retrieved 2026-10-31)
- Started: 2013-04 (actual) (ClinicalTrials.gov record NCT01850056, source copy `cardio:ctgov-nct01850056-2018-07-12`, retrieved 2026-10-31)
- Primary completion: 2016-08 (actual) (ClinicalTrials.gov record NCT01850056, source copy `cardio:ctgov-nct01850056-2018-07-12`, retrieved 2026-10-31)
- Completion: 2016-09 (actual) (ClinicalTrials.gov record NCT01850056, source copy `cardio:ctgov-nct01850056-2018-07-12`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT01850056, source copy `cardio:ctgov-nct01850056-2018-07-12`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01850056-2018-07-12`, retrieved 2026-10-31)

## The registry's words

- Brief title: AcoArt Ⅰ / SFA China
- Condition: Peripheral Artery Disease
- Intervention (Device): drug eluting balloon catheter (trade name: Orchid)
- Intervention (Device): common percutaneous transluminal angioplasty balloon catheter (trade name: Admiral)
- Lead sponsor: Acotec Scientific Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Acotec Scientific Co., Ltd (`cardio:org-acotec-scientific-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study (`cardio:pubmed-32903168`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d52c257b23ca9f5c2b4c0e3f8ef306a4e192eff66b714f337d28edfe1bff6701
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
